Literature DB >> 27832054

Epilepsy Among Iraq and Afghanistan War Veterans - United States, 2002-2015.

Mary Jo Pugh, Anne C Van Cott, Megan Amuan, Christine Baca, Paul Rutecki, Matthew M Zack, Rosemarie Kobau.   

Abstract

The age-adjusted prevalence of seizure disorder in United States veterans deployed in Iraq and Afghanistan conflicts (IAV) is 6.1 per 1,000 persons (1), compared with 7.1 to 10 per 1,000 persons in the general population (2,3). Persons with epilepsy are at risk of excess mortality in part because of comorbidity (4). Although patterns of comorbidity have been associated with mortality in IAV (5), the unique contribution of epilepsy to excess mortality in IAV is unknown. A cohort study was developed using inpatient, outpatient, and pharmacy data from the U.S. Department of Veterans Affairs, Veterans Health Administration (VA) to identify epilepsy, demographic characteristics, and baseline comorbidity for IAV who received VA care in 2010 and 2011. The VA's vital status records were used to identify 5-year mortality (2011-2015). The unadjusted Kaplan-Meier estimator and adjusted proportional hazards regression models tested the hypothesis that excess mortality is associated with epilepsy. IAV with epilepsy were more likely than those without epilepsy to have mental and physical comorbidity, and significantly higher mortality, even after controlling for demographic characteristics and other comorbid conditions (adjusted hazard ratio = 2.6; 95% confidence interval [CI] 2.1-3.2). IAV with epilepsy could benefit from evidence-based chronic disease self-management programs to reduce physical and psychiatric comorbidity, and linkages to VA clinical and other community health and social service providers.

Entities:  

Mesh:

Year:  2016        PMID: 27832054     DOI: 10.15585/mmwr.mm6544a5

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  6 in total

1.  Impact of Clinical Pharmacists on Access to Care in an Epilepsy Clinic.

Authors:  Maralena Taube; Robert Kotloski; Ariela Karasov; John C Jones; Barry Gidal
Journal:  Fed Pract       Date:  2022-04-14

2.  Multimodal Quality of Life Assessment in Post-9/11 Veterans With Epilepsy: Impact of Drug Resistance, Traumatic Brain Injury, and Comorbidity.

Authors:  James J Gugger; Eamonn Kennedy; Samin Panahi; David F Tate; Ali Roghani; Anne C Van Cott; M Raquel Lopez; Hamada Altalib; Ramon Diaz-Arrastia; Mary Jo Pugh
Journal:  Neurology       Date:  2022-04-06       Impact factor: 11.800

3.  Traumatic Brain Injury and Early Onset Dementia in Post 9-11 Veterans.

Authors:  Eamonn Kennedy; Samin Panahi; Ian J Stewart; David F Tate; Elisabeth A Wilde; Kimbra Kenney; J Kent Werner; Jessica Gill; Ramon Diaz-Arrastia; Megan Amuan; Anne C Van Cott; Mary Jo Pugh
Journal:  Brain Inj       Date:  2022-02-05       Impact factor: 2.167

4.  Antiepileptic Drugs and Suicidality in Veterans with Seizures.

Authors:  Shawniqua Williams Roberson; Rizwana Rehman; Gabriel Bucurescu
Journal:  Neurology (ECronicon)       Date:  2019-11-07

Review 5.  Antiepileptic drugs and suicide-related behavior: Is it the drug or comorbidity?

Authors:  Hari K Raju Sagiraju; Chen-Pin Wang; Megan E Amuan; Anne C Van Cott; Hamada H Altalib; Mary Jo V Pugh
Journal:  Neurol Clin Pract       Date:  2018-08

6.  The Military Injuries: Understanding Post-Traumatic Epilepsy Study: Understanding Relationships among Lifetime Traumatic Brain Injury History, Epilepsy, and Quality of Life.

Authors:  Mary Jo Pugh; Eamonn Kennedy; James J Gugger; Jamie Mayo; David Tate; Alicia Swan; Jacob Kean; Hamada Altalib; Shaila Gowda; Alan Towne; Sidney Hinds; Anne Van Cott; Maria R Lopez; Carlos A Jaramillo; Blessen C Eapen; Randall R McCafferty; Martin Salinsky; Joyce Cramer; Katherine K McMillan; Andrea Kalvesmaki; Ramon Diaz-Arrastia
Journal:  J Neurotrauma       Date:  2021-10-15       Impact factor: 4.869

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.